Bacteriological Profile of Neonatal Sepsis inNeonatal Intermediate Care Unit of Central Paediatric Referral Hospital in Nepal
Background: Sepsis is one of the leading causes of neonatal morbidity and mortality. Because of difference in localepidemiology and possible variation with time, regular monitoring and updates on pathogen and their antimicrobialsensitivity pattern is important for prevention and treatment.
Methods: A retrospective descriptive study was carried out among cases of neonatal sepsis admitted in neonatalintermediate care unit of Kanti Childrenâ€™s hospital from August 2014 to August 2015. The data was collected from medical records of neonatal intermediate care unit and microbiology department and analyzed using SPSS version 20.
Results: There were 644 admissions, among which 210 (32%)were suspected of having neonatal sepsis. Thirty(14%)of the suspected cases had positive blood culture. Proportions of late and early onset were 25 (83.3%) and 5(17.7%)respectively.In blood culture Staphylococcus aureus was the most common organism(80%),followed by Coagulasenegative Staphylococcus (6.66%), Acinetobacter (6.66%), Enterobacter species(3.33%) and Morgonellamorgoni(3.33.5%).Gram positive organisms were isolated in all cases of early onset sepsis and in 84% of late onset sepsis. Mostof the isolated organisms showed sensitivity to amikacin, cloxacillin, ciprofloxacin and vancomycin.
Conclusions: This study has indicated possible emergence of Staphylococcus aureus as the dominant cause of neonatalsepsis. Cloxacillin, amikacin, ciprofloxacin have high proportion of efficacy against the commonly isolated bacteria inneonatal sepsis.Keywords: Neonatal sepsis; drug sensitivity; risk factor.
Journal of Nepal Health Research Council JNHRC allows to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNHRC work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).